Clustering data with hclust algorithm for (Study ST003973)
Reversed phase POSITIVE ION MODE (Analysis AN006543)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1-Aminocyclopropane-1-carboxylate | ME1049585 | 0.91 | 0.88 | 1.89 | 1.80 | 0.28 | 0.18 | 1.31 | 1.23 | 0.67 | 0.61 |
| 2-Acetyl-aminoadipate | ME1049646 | 0.49 | 0.49 | 3.23 | 3.33 | 0.46 | 0.48 | 0.34 | 0.66 | 0.19 | 0.35 |
| 1-Pyrroline-4-hydroxy-2-carboxylate 3 | ME1049602 | 0.83 | 0.95 | 1.55 | 1.61 | 0.73 | 0.70 | 0.97 | 0.94 | 0.82 | 0.89 |
| 2-Amino-6-oxopimelate | ME1049640 | 1.68 | 2.74 | 0.04 | 0.04 | 0.82 | 0.85 | 1.06 | 1.03 | 0.86 | 0.88 |
| 2,6-Diaminoheptanedioate 1 | ME1049642 | 3.23 | 3.28 | 0.28 | 0.43 | 0.02 | 0.01 | 0.51 | 0.61 | 0.60 | 0.72 |
| 2,6-Diaminopelate 2 | ME1049643 | 1.43 | 1.97 | 0.05 | 0.05 | 0.14 | 0.15 | 1.29 | 1.53 | 1.49 | 1.80 |
Factors:
| F1 | Sample source:extensively drug-resistant strain | treatment:Control |
| F2 | Sample source:extensively drug-resistant strain | treatment:Trehalose |
| F3 | Sample source:multidrug-resistant strain | treatment:Control |
| F4 | Sample source:multidrug-resistant strain | treatment:Trehalose |
| F5 | Sample source:Rifampicin-resistant strain | treatment:Control |
| F6 | Sample source:Rifampicin-resistant strain | treatment:Trehalose |
| F7 | Sample source:sensitive strain | treatment:Control |
| F8 | Sample source:sensitive strain | treatment:Trehalose |
| F9 | Sample source:totally drug-resistant strain | treatment:Control |
| F10 | Sample source:totally drug-resistant strain | treatment:Trehalose |
